Pages that link to "Q33603337"

The following pages link to Oral tolerance in the treatment of inflammatory autoimmune diseases (Q33603337):

Displaying 27 items.

• Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy (Q28344712) (← links)
• Mechanisms of Natural Tolerance in the Intestine (Q29031968) (← links)
• Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. (Q33447479) (← links)
• Functional Transforming Growth Factor-β Receptor Type II Expression by CD4 T Cells in Peyer's Patches Is Essential for Oral Tolerance Induction (Q34075716) (← links)
• Antigen-specific therapy for autoimmune disease (Q34096269) (← links)
• Understanding the pathogenesis of autoimmune hepatitis (Q34227816) (← links)
• A revisit of mucosal IgA immunity and oral tolerance (Q34419871) (← links)
• Vaccines against myasthenia gravis. (Q34433908) (← links)
• Current therapy for autoimmune hepatitis (Q34615157) (← links)
• Peyer's patches are required for oral tolerance to proteins (Q34725322) (← links)
• Treatment strategies in autoimmune hepatitis (Q34936764) (← links)
• Oral tolerance for treating uveitis - new hope for an old immunological mechanism (Q34998321) (← links)
• Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis (Q35030822) (← links)
• An HLA-peptide mimics organ-specific antigen in autoimmune uveitis: its role in pathogenesis and therapeutic induction of oral tolerance (Q35171938) (← links)
• Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly (Q37106402) (← links)
• Current and future treatments of autoimmune hepatitis (Q37503380) (← links)
• Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis (Q37682722) (← links)
• Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit (Q38606892) (← links)
• Lymph node trafficking of regulatory T cells is prerequisite for immune suppression (Q40349858) (← links)
• Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4 T cells (Q42176939) (← links)
• Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis. (Q44461538) (← links)
• Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis (Q45242443) (← links)
• Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. (Q45966480) (← links)
• The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes (Q47904800) (← links)
• Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes (Q73943062) (← links)
• Inhalant induces tolerance against stroke (Q78839865) (← links)
• Non-NSAID over-the-counter (OTC) remedies for arthritis: good, bad or indifferent? (Q80633772) (← links)